HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stirling, D. Articles by Simpson, E. R. Search for Related Content PubMed PubMed Citation Articles by Stirling, D. Articles by Simpson, E. R. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 1, 5-8, Jan, 1990

Angiotensin II inhibits luteinizing hormone-stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture

D Stirling, RR Magness, R Stone, MR Waterman and ER Simpson
Cecil H. and Ida Green Center for Reproductive Biology Sciences, Department of Obstetrics-Gynecology, University of Texas, Southwestern Medical Center, Dallas 75235.

Angiotensin II has been identified immunohistochemically in the ovaries of both rats and humans. Here we present evidence that angiotensin II (an extremely vasoactive agent in a wide range of tissues) may be involved in the regulation of the major steroidogenic enzyme in the ovary, cholesterol side chain cleavage cytochrome P-450 (P-450scc), as well as of basic fibroblast growth factor (bFGF), which has been implicated as an angiogenic factor in the bovine corpus luteum. We have used primary cultures of bovine luteal cells to examine the effect of angiotensin II and its receptor antagonist, saralasin, on expression of mRNA encoding bFGF as well as on progesterone production and the expression of mRNA encoding cholesterol side chain cleavage cytochrome P-450 (P-450scc). Neither angiotensin II nor saralasin when added alone to the culture medium had any effect on basal progesterone production. Luteinizing hormone (LH) caused a 15-fold increase in progesterone accumulation after 24 h of exposure which was reduced to 5-fold in the presence of angiotensin II. This appeared to be receptor-mediated in that although saralasin alone had no effect on LH-stimulated progesterone accumulation, it significantly reversed the inhibition by angiotensin II. This pattern was mirrored by the levels of mRNA encoding P-450scc, i.c., LH induced the highest levels of expression of this message, these levels were reduced by angiotensin II, and saralasin partially overcame this reduction. Levels of mRNA encoding bFGF were elevated by both LH and angiotensin II. Treatment with saralasin, however, resulted in complete inhibition of bFGF mRNA expression in the presence of both LH and angiotensin II. These results suggest a role for angiotensin II to mediate the action of LH as a regulator of bFGF expression and hence, potentially, angiogenesis. Local production of angiotensin II might also contribute to the refractoriness of luteal progesterone secretion to LH at the time of luteal regression.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. R. Pepperell, G. Nemeth, Y. Yamada, F. Naftolin, and M. Merino Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E221 - E233. [Abstract] [Full Text] [PDF]

				J. Zheng, I. M. Bird, D.-B. Chen, and R. R. Magness Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide J. Physiol., May 15, 2005; 565(1): 59 - 69. [Abstract] [Full Text] [PDF]

				T.P. Neuvians, D. Schams, B. Berisha, and M.W. Pfaffl Involvement of Pro-Inflammatory Cytokines, Mediators of Inflammation, and Basic Fibroblast Growth Factor in Prostaglandin F2{alpha}-Induced Luteolysis in Bovine Corpus Luteum Biol Reprod, February 1, 2004; 70(2): 473 - 480. [Abstract] [Full Text] [PDF]

				I. V. Iosipiv and M. Schroeder A role for angiotensin II AT1 receptors in ureteric bud cell branching Am J Physiol Renal Physiol, August 1, 2003; 285(2): F199 - F207. [Abstract] [Full Text] [PDF]

				S.-i. Kobayashi, T. J. Acosta, T. Ozawa, K. Hayashi, B. Berisha, M. Ohtani, D. Schams, and A. Miyamoto Intraluteal Release of Angiotensin II and Progesterone In Vivo During Corpora Lutea Development in the Cow: Effect of Vasoactive Peptides Biol Reprod, January 1, 2002; 66(1): 174 - 179. [Abstract] [Full Text]

				K.H. Schauser, A.H. Nielsen, H. Winther, V. Dantzer, and K. Poulsen Localization of the Renin-Angiotensin System in the Bovine Ovary: Cyclic Variation of the Angiotensin II Receptor Expression Biol Reprod, December 1, 2001; 65(6): 1672 - 1680. [Abstract] [Full Text] [PDF]

				T.J. Acosta, T. Ozawa, S. Kobayashi, K. Hayashi, M. Ohtani, W.D. Kraetzl, K. Sato, D. Schams, and A. Miyamoto Periovulatory Changes in the Local Release of Vasoactive Peptides, Prostaglandin F2{alpha}, and Steroid Hormones from Bovine Mature Follicles In Vivo Biol Reprod, November 1, 2000; 63(5): 1253 - 1261. [Abstract] [Full Text]

				K. Hayashi, A. Miyamoto, B. Berisha, M. R. Kosmann, K. Okuda, and D. Schams Regulation of Angiotensin II Production and Angiotensin Receptors in Microvascular Endothelial Cells from Bovine Corpus Luteum Biol Reprod, January 1, 2000; 62(1): 162 - 167. [Abstract] [Full Text]

				K. Hayashi and A. Miyamoto Angiotensin II Interacts with Prostaglandin F2{alpha} and Endothelin-1 as a Local Luteolytic Factor in the Bovine Corpus Luteum In Vitro Biol Reprod, May 1, 1999; 60(5): 1104 - 1109. [Abstract] [Full Text]

				M. Bramucci, A. Miano, A. Gobbetti, M. Zerani, L. Quassinti, E. Maccari, O. Murri, and D. Amici Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R2089 - R2096. [Abstract] [Full Text] [PDF]

				M. M. Hinshelwood, M. D. Michael, and E. R. Simpson The 5'-Flanking Region of the Ovarian Promoter of the Bovine CYP19 Gene Contains a Deletion in a Cyclic Adenosine 3',5'-Monophosphate-Like Responsive Sequence Endocrinology, September 1, 1997; 138(9): 3704 - 3710. [Abstract] [Full Text] [PDF]

				R. Borroni, Z. Liu, E. R. Simpson, and M. M. Hinshelwood A Putative Binding Site for Sp1 Is Involved in Transcriptional Regulation of CYP17 Gene Expression in Bovine Ovary Endocrinology, May 1, 1997; 138(5): 2011 - 2020. [Abstract] [Full Text] [PDF]

				Z. Liu and E. R. Simpson Steroidogenic Factor 1 (SF-1) and SP1 Are Required for Regulation of Bovine CYP11A Gene Expression in Bovine Luteal Cells and Adrenal Y1 Cells Mol. Endocrinol., February 1, 1997; 11(2): 127 - 137. [Abstract] [Full Text]

				M. D. Michael, M. W. Kilgore, K.-i. Morohashi, and E. R. Simpson Ad4BP/SF-1 Regulates Cyclic AMP-induced Transcription from the Proximal Promoter (PII) of the Human Aromatase P450 (CYP19) Gene in the Ovary J. Biol. Chem., June 2, 1995; 270(22): 13561 - 13566. [Abstract] [Full Text] [PDF]

				G. Nemeth, J. R. Pepperell, Y. Yamada, A. Palumbo, and F. Naftolin The Basis and Evidence of a Role for the Ovarian Renin-Angiotensin System in Health and Disease Reproductive Sciences, April 1, 1994; 1(2): 118 - 127. [Abstract] [PDF]